Peter Mitchell is a highly experienced leader in bioprocesses, currently serving as the Chief Operations Officer (COO) and Head of R&D at Cellcraft since 2025. With a rich background in process development and manufacturing of advanced therapy medicinal products (ATMPs) and biologics, they previously held senior roles at companies like GammaDelta Therapeutics and Takeda Oncology. Peter's academic credentials include a PhD in skeletal tissue engineering from Southampton University and a Master of Biology from the University of Bath. Their extensive experience encompasses development, operations, and strategic leadership within multidisciplinary scientific teams.
This person is not in the org chart
This person is not in any teams
This person is not in any offices